The next board meeting for Verrica Pharma Inc is on 19 May 2026 for the purpose of H.C. Wainwright 4th Annual BioConnect Investor ConferenceSee details
Verrica Pharma Inc has a share price target of US$ 16, revenue growth forecast of -28.6%, and profit growth estimate of -116.9% for FY26, based on top 5 analyst calls.